Zacks Research Analysts Cut Earnings Estimates for Danaher

Danaher Corporation (NYSE:DHR) – Zacks Research cut their Q2 2026 EPS estimates for shares of Danaher in a research report issued on Thursday, December 18th. Zacks Research analyst Team now forecasts that the conglomerate will post earnings of $1.92 per share for the quarter, down from their previous estimate of $1.93. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher’s Q3 2026 earnings at $1.96 EPS and FY2026 earnings at $8.31 EPS.

Danaher (NYSE:DHR) last posted its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the firm posted $1.71 EPS. The company’s revenue was up 4.4% on a year-over-year basis.

Other research analysts also recently issued research reports about the company. Morgan Stanley assumed coverage on Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 price target on the stock. Wells Fargo & Company upped their price target on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research report on Monday. JPMorgan Chase & Co. raised their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a report on Thursday. Finally, Redburn Partners set a $220.00 price target on Danaher in a report on Wednesday, October 8th. Twenty-one analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $248.25.

Danaher Stock Performance

Shares of DHR stock opened at $224.43 on Friday. Danaher has a 1 year low of $171.00 and a 1 year high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a market cap of $158.53 billion, a price-to-earnings ratio of 46.28, a PEG ratio of 4.32 and a beta of 0.89. The stock’s 50-day moving average is $219.93 and its two-hundred day moving average is $206.66.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a $0.32 dividend. The ex-dividend date is Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Insider Buying and Selling at Danaher

In other Danaher news, Director Teri List sold 3,298 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. The trade was a 13.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the sale, the senior vice president directly owned 2,625 shares of the company’s stock, valued at $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.10% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Danaher

Large investors have recently made changes to their positions in the stock. Saranac Partners Ltd purchased a new stake in Danaher during the third quarter worth about $4,485,000. Allworth Financial LP lifted its position in shares of Danaher by 29.8% during the 3rd quarter. Allworth Financial LP now owns 6,621 shares of the conglomerate’s stock valued at $1,313,000 after acquiring an additional 1,522 shares during the period. Swiss Life Asset Management Ltd boosted its stake in shares of Danaher by 12.1% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 102,919 shares of the conglomerate’s stock worth $20,405,000 after acquiring an additional 11,129 shares in the last quarter. Groupama Asset Managment grew its holdings in shares of Danaher by 2.2% in the 3rd quarter. Groupama Asset Managment now owns 44,434 shares of the conglomerate’s stock worth $8,809,000 after acquiring an additional 972 shares during the period. Finally, Investment Research Partners LLC purchased a new position in Danaher in the 3rd quarter valued at approximately $368,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.